SEARCH
= Registered usersThe Practitioner 2007;251(1696):19
HPV prevalence underestimated
01 Jul 2007
A study from the USA reinforces the recent recommendation of the US Advisory Committee on Immunization Practices that the new human papillomavirus (HPV) vaccine should be offered to all girls aged 11 and 12.
This article can be accessed only if you are a paid-up subscriber to The Practitioner.